These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)]. Drugeon HB; Courtieu AL Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083 [TBL] [Abstract][Full Text] [Related]
63. Effect of structural modifications on the biological properties of aminoglycoside antibiotics containing 2-deoxystreptamine. Price KE; Godfrey JC Adv Appl Microbiol; 1974; 18(0):191-307. PubMed ID: 4613147 [No Abstract] [Full Text] [Related]
64. [Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)]. Skalova R; Hajsig D; Babić I; Mostovac D Lijec Vjesn; 1978 Nov; 100(11):708-10. PubMed ID: 107386 [No Abstract] [Full Text] [Related]
65. A novel method of assaying antimicrobial agents by particle microelectrophoresis. Furr JR; Davies G; Adebiyi AR; Russell AD J Appl Bacteriol; 1981 Feb; 50(1):173-6. PubMed ID: 7014546 [No Abstract] [Full Text] [Related]
66. In vitro evaluation of a new aminoglycoside derivative of kanamycin, a comparison with tobramycin and gentamycin. Ries K; Levison ME; Kaye D Antimicrob Agents Chemother; 1973 Apr; 3(4):532-3. PubMed ID: 4790607 [TBL] [Abstract][Full Text] [Related]
68. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance]. Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424 [TBL] [Abstract][Full Text] [Related]
69. [Study of sensitivity of clinical strains of microorganisms to ampicillin and other broad spectrum antibiotics]. Chavdarova VB; Petrova MA; Navashin SM Antibiotiki; 1969 Feb; 14(2):151-4. PubMed ID: 4976747 [No Abstract] [Full Text] [Related]
70. ["In vitro" activity of gentamicin. Research of bacterial strains isolated from various forms of morbidity]. Panero C; Pieri J G Ital Chemioter; 1969; 16(1):60-3. PubMed ID: 4998311 [No Abstract] [Full Text] [Related]
71. Synthesis and antibacterial activity of 1-N-[(S)-ω-amino-2-hydroxyalkyl] derivatives of dibekacin, 5-deoxydibekacin, 3'-deoxykanamycin A and gentamicin B. Umemura E; Sakamoto Y; Takahashi Y; Miyake T J Antibiot (Tokyo); 2015 Jun; 68(6):421-3. PubMed ID: 25712399 [No Abstract] [Full Text] [Related]
74. [Comparative study of tobramycin and gentamicin]. Klastersky J; Daneau D; Henri A Acta Clin Belg; 1972; 27(5):589-99. PubMed ID: 4205788 [No Abstract] [Full Text] [Related]
75. Cross-resistance of Pseudomonas to gentamicin and tobramycin. Brusch JL; Barza M; Bergeron MG; Weinstein L Antimicrob Agents Chemother; 1972 Mar; 1(3):280-1. PubMed ID: 4625628 [TBL] [Abstract][Full Text] [Related]
76. Aminoglycosides from the clinical microbiologist's viewpoint. Schoenknecht FD Int J Clin Pharmacol Biopharm; 1975 Mar; 11(2):103-11. PubMed ID: 237839 [TBL] [Abstract][Full Text] [Related]
77. [Variations in the sensitivity of gram negative bacteria to 4 aminoglycoside antibiotics, during 3 years of observations]. Luna Castro M; Escárzaga TE Rev Latinoam Microbiol; 1974; 16(1):13-9. PubMed ID: 4527594 [No Abstract] [Full Text] [Related]
78. Properties of glycosides of neamine, kanamycin A and gentamicin C. Perlman D; Endō T; Hinz RS; Cowan SK; Endō S J Antibiot (Tokyo); 1974 Jul; 27(7):525-8. PubMed ID: 4457532 [No Abstract] [Full Text] [Related]